USA - engelsk - NLM (National Library of Medicine)

inmotion products llc - menthol 4%, trolamine salicylate 2% - topical analgesic for the temporary relief of minor aches and pains of muscles and joints associated with: - arthritis - simple backache - muscle strains - sprains - bruises - cramps

USA - engelsk - NLM (National Library of Medicine)

inmotion products llc - menthol 3%, trolamine salicylate 2% - topical analgesic for the temporary relief of minor aches and pains of muscles and joints associated with: - arthritis - simple backache - muscle strains - sprains - bruises - cramps

USA - engelsk - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - mycophenolate mofetil (unii: 9242ecw6r0) (mycophenolic acid - unii:hu9dx48n0t) - mycophenolate mofetil 250 mg

USA - engelsk - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - mycophenolate mofetil (unii: 9242ecw6r0) (mycophenolic acid - unii:hu9dx48n0t) - mycophenolate mofetil 500 mg

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - mycophenolate mofetil 250mg;   - capsule - 250 mg - active: mycophenolate mofetil 250mg   excipient: croscarmellose sodium gelatin magnesium stearate povidone pregelatinised maize starch - cellcept is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. cellcept is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - mycophenolate mofetil 500mg (as 542 mg of the hydrochloride salt);   - powder for infusion - 500 mg - active: mycophenolate mofetil 500mg (as 542 mg of the hydrochloride salt)   excipient: citric acid polysorbate 80 sodium chloride - cellcept is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. cellcept is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - mycophenolate mofetil 200 mg/ml;   - powder for oral suspension - 200 mg/ml - active: mycophenolate mofetil 200 mg/ml   excipient: aspartame citric acid colloidal silicon dioxide fruit mix flavour 274869 lecithin methyl hydroxybenzoate sodium citrate dihydrate sorbitol xanthan gum - cellcept is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. cellcept is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - mycophenolate mofetil 500mg;   - tablet - 500 mg - active: mycophenolate mofetil 500mg   excipient: croscarmellose sodium magnesium stearate microcrystalline cellulose opadry lavender y-5-10272-a povidone - cellcept is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. cellcept is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.

USA - engelsk - NLM (National Library of Medicine)

strategic sourcing services llc - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - antiemetic for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness.

USA - engelsk - NLM (National Library of Medicine)

top care (topco associates llc) - dimenhydrinate (unii: jb937per5c) (diphenhydramine - unii:8gts82s83m) - antiemetic for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness.